Clinical Trial Update: Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing adding omega-3 fish oil to palliative chemotherapy for esophageal and gastric cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Omega-3 Fish Oil (omega-3 fatty acids)

Snippet

Sponsor: University Hospitals, Leicester | Conditions: Esophageal Neoplasm, Gastric Neoplasm | Phase 2 | Status: TERMINATED